Log in

MECURE Mecure Industries PLC NSENG · Nigeria

Mecure Industries (MECURE) news

Mecure Industries PLC is a public biotech or pharmaceutical company listed on NSENG under the ticker MECURE, recorded under Nigeria. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest Mecure Industries news

We have not published a story on Mecure Industries yet. When there is news, it will appear here.

Questions about Mecure Industries

What is the ticker symbol of Mecure Industries?

Mecure Industries PLC trades under the ticker MECURE on NSENG.

Where is Mecure Industries listed?

Mecure Industries PLC is listed on NSENG.

Which country or territory is Mecure Industries listed under?

Our directory records Mecure Industries PLC under Nigeria.

What does Mecure Industries do?

Our directory classifies Mecure Industries PLC as: Pharmaceuticals: Major. This is a directory classification, not a description of the pipeline.

What is the ISIN of Mecure Industries?

The ISIN recorded for Mecure Industries PLC is NGMECURE0006.

Does aibio.space cover Mecure Industries?

aibio.space lists Mecure Industries PLC among 2,820 public biotech companies and publishes its news here as stories appear.

Which companies are similar to Mecure Industries?

Companies in our directory listed in the same country and business area as Mecure Industries: Morison Industries, Pharma-Deko, Neimeth International Pharmaceuticals, Fidson Healthcare, May & Baker Nigeria Plc.

Investor discussion: Mecure Industries

Members talk about Mecure Industries (MECURE). Reader posts, not aibio.space reporting, and not investment advice.

Rules
  1. Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
  2. Say whether you hold the stock. Every post states long, short or no position.
  3. No paid or sponsored posts. Do not post for anyone who pays or rewards you.
  4. No buy or sell calls and no price targets.
  5. No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
  6. No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Listing details

Mecure Industries PLC is a public biotech or pharmaceutical company listed on NSENG under the ticker MECURE, recorded under Nigeria. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Company
Mecure Industries PLC
Ticker
MECURE
Listing
NSENG
Country or territory
Nigeria
Business scope
Pharmaceuticals: Major
ISIN
NGMECURE0006
Last quote in directory
2026-10-21
Directory source
Listing page

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction

Full desks

Every other company has a starter desk. Search above to open one.

Settings

Appearance
Text size
Motion

Stops the news strip and the share rollers.

Your choices are saved in this browser only.

Free membership

Read aibio.space in full, free

Subscribe with your email address to read every story, company desk and profile in full. It costs nothing. In return, you agree that we may email you, including offers. One click to unsubscribe.

No card, no password. With email, we send one message to confirm your address first. With Google or Facebook we receive only your email address. Not investment advice.